Literature DB >> 10692409

Mutational analysis of basic residues in the rat vesicular acetylcholine transporter. Identification of a transmembrane ion pair and evidence that histidine is not involved in proton translocation.

M H Kim1, M Lu, M Kelly, L B Hersh.   

Abstract

The function of positively charged residues and the interaction of positively and negatively charged residues of the rat vesicular acetylcholine transporter (rVAChT) were studied. Changing Lys-131 in transmembrane domain helix 2 (TM2) to Ala or Leu eliminated transport activity, with no effect on vesamicol binding. However, replacement by His or Arg retained transport activity, suggesting a positive charge in this position is critical. Mutation of His-444 in TM12 or His-413 in the cytoplasmic loop between TM10 and TM11 was without effect on ACh transport, but vesamicol binding was reduced with His-413 mutants. Changing His-338 in TM8 to Ala or Lys did not effect ACh transport, however replacement with Cys or Arg abolished activity. Mutation of both of the transmembrane histidines or all three of the luminal loop histidines showed no change in acetylcholine transport. The mutant H338A/D398N between oppositely charged residues in transmembrane domains showed no vesamicol binding, however the charge reversal mutant H338D/D398H restored binding. This suggests that His-338 forms an ion pair with Asp-398. The charge neutralizing mutant K131A/D425N or the charge exchanged mutant K131D/D425K did not restore ACh transport. Taken together these results provide new insights into the tertiary structure in VAChT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692409     DOI: 10.1074/jbc.275.9.6175

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Structural conservation in the major facilitator superfamily as revealed by comparative modeling.

Authors:  Eyal Vardy; Isaiah T Arkin; Kay E Gottschalk; H Ronald Kaback; Shimon Schuldiner
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

2.  A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo.

Authors:  Anna Grygoruk; Hao Fei; Richard W Daniels; Bradley R Miller; Aaron Diantonio; David E Krantz
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

3.  Specificity of the rat vesicular acetylcholine transporter.

Authors:  Myung-Hee Kim; Mei Lu; Gary Rogers; Stanley Parsons; Louis B Hersh
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

4.  Search for the acetylcholine and vesamicol binding sites in vesicular acetylcholine transporter: the region around the lumenal end of the transport channel.

Authors:  Parul Khare; Anuprao Mulakaluri; Stanley M Parsons
Journal:  J Neurochem       Date:  2010-10-12       Impact factor: 5.372

5.  Possible important pair of acidic residues in vesicular acetylcholine transporter.

Authors:  Parul Khare; Ana M Ojeda; Ananda Chandrasekaran; Stanley M Parsons
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

6.  Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Authors:  Dana Yaffe; Sebastian Radestock; Yonatan Shuster; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

7.  Synaptic vesicle protein 2 binds adenine nucleotides.

Authors:  Jia Yao; Sandra M Bajjalieh
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

8.  Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol.

Authors:  Parul Khare; Aubrey R White; Stanley M Parsons
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

9.  A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.

Authors:  Ashutosh A Kulkarni; Daryl L Davies; Jennifer S Links; Leena N Patel; Vincent H L Lee; Ian S Haworth
Journal:  Pharm Res       Date:  2006-09-29       Impact factor: 4.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.